Company · CIK 1657677
Parabilis Medicines, Inc.
| CIK | 1657677 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | PBLS (Nasdaq) |
| First annual or quarterly report | 2026-08-13 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-296032 | 2026-05-19 | 2026-06-10 | 6 |
Filings
7| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-10 | 424B4Final prospectus | 333-296032 | 0001193125-26-265983 |
| 2026-06-09 | EFFECTDeclared effective | 333-296032 | 9999999995-26-001929 |
| 2026-06-09 | S-1/AAmendment | 333-296032 | 0001193125-26-262880 |
| 2026-06-04 | S-1/AAmendment | 333-296032 | 0001193125-26-256398 |
| 2026-05-27 | S-1/AAmendment | 333-296032 | 0001193125-26-242067 |
| 2026-05-19 | S-1Registration filed | 333-296032 | 0001193125-26-230994 |
| 2026-04-02 | DRSDraft made public | 377-09210 | 0001193125-26-140488 |